| Marisa Danielle Castanon, | |
|
7745 Leeds St, Downey, CA 90242-3489 | |
| (310) 221-6336 | |
| Not Available |
| Full Name | Marisa Danielle Castanon |
|---|---|
| Gender | Female |
| Speciality | Social Worker |
| Location | 7745 Leeds St, Downey, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083263156 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Marisa Danielle Castanon, 7745 Leeds St, Downey, CA 90242-3489 Ph: (310) 221-6336 | Marisa Danielle Castanon, 7745 Leeds St, Downey, CA 90242-3489 Ph: (310) 221-6336 |
News Archive
There is an urgent need for new drugs to treat Rett syndrome, a rare and severe neurological disease mainly affecting girls. A bottleneck in drug development for this syndrome is a lack of clarity at the level of preclinical research. Key researchers in this field now tackle this issue, proposing standards and guidelines for Rett syndrome research, in an Open Access review article published on Oct. 31, 2012 in Disease Models & Mechanisms (DMM).
In recent study, researchers analyzed COVID-19 data obtained from Israel to determine whether the Alpha variant led to a higher fatality rate.
Nu Skin Enterprises, Inc. today announced record third-quarter results with revenue of $927.6 million, a 76 percent increase over the prior-year period. Revenue was negatively impacted 3 percent by foreign currency fluctuations. Earnings per share for the quarter were $1.80, a 107 percent year-over-year improvement.
A new research letter published by JAMA Pediatrics examined trends in overall and cause-specific infant mortality rates between non-Hispanic black and white infants because infant mortality is an important indicator of population health.
Genentech Inc., now part of Swiss drug developer Roche, and Biogen Idec Inc. on Sunday have announced positive and encouraging results from a clinical study of cancer drug Rituxan in patients with advanced type of non-Hodgkin's lymphoma. An estimated 65,540 people in the US were diagnosed with non-Hodgkin's lymphoma this year, and follicular lymphoma accounts for about 15 to 20 percent of those cases. The disease can occur at any time during adulthood, though people are typically diagnosed during their 50s and 60s.
› Verified 9 days ago